Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
12/2010
12/08/2010CN101904930A Medicament for treating scald
12/08/2010CN101904929A Medicament for treating psoriasis and preparation method
12/08/2010CN101904928A Ointment for treating psoriasis
12/08/2010CN101904915A Chinese medicinal composition for promoting fast recovery of burn
12/08/2010CN101904911A External application drug for treating eczema and preparation method thereof
12/08/2010CN101904908A Anti-hair loss traditional Chinese medicine composition, preparation method and application thereof to preparing anti-hair loss products
12/08/2010CN101904889A Method for identifying isatis root in Chinese medicinal preparations
12/08/2010CN101904884A Quality detection method for Chinese medicinal compound isatis root granules
12/08/2010CN101904872A Use of probiotic microorganisms for limiting cutaneous irrittations
12/08/2010CN101904855A Anti-anaphylaxis and sterilization combined injection
12/08/2010CN101904853A Liquid for curing tinea pedis
12/08/2010CN101904833A Salvianic acid A medical composition and preparation method thereof
12/08/2010CN101904831A Application of alkannin and compositions thereof
12/08/2010CN101904817A Cefsulodin sodium liposome injection
12/08/2010CN101904800A Microcomputer traditional Chinese medical eutrophicated auxiliary treatment instrument for skin diseases
12/08/2010CN101569718B Chinese medicament for clearing heat, releasing toxin, removing swelling and dissipating stagnation
12/08/2010CN101460172B Use of allopurinol for the treatment of palmar plantar erythrodysesthesia
12/08/2010CN101390852B Melanogenesis inhibitor and skin preparation containing the same
12/08/2010CN101380317B Pharmaceutical composition for easing pruritus
12/08/2010CN101371880B Chinese medicinal composition for treating empyrosis wound surface
12/08/2010CN101366846B External remedy for body surface burn, scald and ulcer
12/08/2010CN101347563B Medicament for treating baldness and white hair and preparation method thereof
12/08/2010CN101347544B Chinese medicine for treating seborrheic baldness
12/08/2010CN101342224B Externally used drug for burn and scald without scar left
12/08/2010CN101336998B Traditional Chinese medicine for treating whelk
12/08/2010CN101327189B Method for preparing nano alcohol liposome material with mark and treatment double-function
12/08/2010CN101301345B Burn treating medicine
12/08/2010CN101284121B Combination medicine for curing the hoary hair
12/08/2010CN101278943B Externally-applied medicine for curing psora
12/08/2010CN101254155B Skin preparations for external use
12/08/2010CN101181431B Coptis cream for taking poison and growing muscle due to empyrosis as well as preparation method thereof
12/08/2010CN101180028B Use of adamantyl methoxydi phenyl propenoic acid for the treatment of acne
12/08/2010CN101168019B External-applied preparation with anti-inflammation, itching-stopping and sterilization function
12/08/2010CN101161688B Novel process for synthesizing povidone iodine by gas phase/ solid phase reaction
12/08/2010CN101152185B Use of heterocyclic compounds as SCCE inhibitors
12/08/2010CN101095447B Health-care coffee having waste-discharging and youth-keeping function and the preparing method thereof
12/08/2010CN101087615B N-acetylglucosamine tablet disintegrating in oral cavity and process for producing the same
12/08/2010CN101072752B Process for producing 2-amino-2-[2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]ethyl]-1,3-propanediol hydrochloride or hydrate thereof and intermediate for the same
12/08/2010CN101032336B Pearl flavone nutrient health care food and preparation process thereof
12/08/2010CN101015333B Olive comprehensive utilization method
12/08/2010CN100998575B Finger nail coating agent of antifungal agent and its preparing method
12/07/2010US7847068 Neutralizing human anti-IGFR antibody
12/07/2010US7846969 Ceramide emulsions
12/07/2010US7846967 isolated from Cnidium officinale and Ligusticum chuanxiong; inhibiting melanocyte-stimulating hormone
12/07/2010US7846947 For treatment of wounds, atopic dermatitides, infected eczemas, dermatomycoses, vaginal infections, acne, herpes and/or for controlling multidrug-resistant pathogens
12/07/2010US7846927 N,N′-diphenylurea derivatives suitable as kinase inhibitors
12/07/2010US7846925 such as 5-(1,3-benzodioxol-5-ylmethylene)-1,3-thiazolidine-2,4-dione, used for the treatment and/or prophylaxis of autoimmune, cardiovascular or neurodegenerative disorders, inflammatory or kidney diseases, bacterial or viral infections, platelet aggregation, cancer, transplant rejection or lung injuries
12/07/2010US7846487 A neutraceutical comprising a dehydrated product of Type II collagen that retains its original natural structure and biological activity, sodium or potassium chloride and water; nonhydrolyzing; storage stability; antiarthritic agents;tablets; capsules; cream; lotion; biodrug; food supplements
12/07/2010CA2616449C Compositions for external application, containing adenosyl cobalamin for improvement of skin diseases
12/07/2010CA2488334C 24-sulfoximine vitamin d3 compounds
12/07/2010CA2460693C Alkyl urea retinoid agonists i
12/07/2010CA2456029C Stable emulsion composition
12/07/2010CA2453263C Pharmaceutical compositions containing terbinafine and use thereof
12/07/2010CA2434203C 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
12/07/2010CA2367304C Cosmetic preparations comprising water-soluble .beta.-(1,3) glucans and desoxyribonucleic acids
12/02/2010WO2010138770A2 Methods for administration and formulations for the treatment of regional adipose tissue
12/02/2010WO2010138519A2 Use of adsorbent carbon microspheres for the treatment of pruritus
12/02/2010WO2010138422A1 Cyclosporin derivatives for enhancing the growth of hair
12/02/2010WO2010137731A1 Pharmaceutical composition comprising prostaglandin derivatives for use in modulating claudin mediated functions and in the treatment of dermatological disorders
12/02/2010WO2010137620A1 Phenoxyethylamine derivative
12/02/2010WO2010137594A1 Polypeptide having antibacterial activity and angiogenesis-inducing activity and wound-healing drug containing said polypeptide
12/02/2010WO2010137484A1 Anti-shock agent comprising diaminotrifluoromethylpyridine derivative
12/02/2010WO2010137350A1 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
12/02/2010WO2010137335A1 TURN-OVER-ACCELERATING COMPOSITION CONTAINING α-LIPOIC ACID NANOPARTICLES
12/02/2010WO2010136570A1 Green tea extracts of improved bioavailability
12/02/2010WO2010136242A1 Bonding products of aminated polysaccharides
12/02/2010WO2010136212A1 Lipoxygenase and its use in wound healing
12/02/2010WO2010088064A3 Preservation of ergothioneine
12/02/2010WO2010087947A3 Transdermal delivery of diclofenac, carbamazepine and benzydamine
12/02/2010US20100305696 Hybrid soft tissue implants from progenitor cells and biomaterials
12/02/2010US20100305214 Use of a Monoterpene to Increase Tissue Repair
12/02/2010US20100305203 Method for modulating claudin mediated functions
12/02/2010US20100305200 Compounds that modulate intracellular calcium
12/02/2010US20100305191 Rna interference mediated inhibition of adenosine a1 receptor (adora1) gene expression using short interfering rna
12/02/2010US20100305178 Pharmaceutical Composition
12/02/2010US20100305164 5-(4-methanesulfonyl-phenyl)-thiazole derivatives for the treatment of acute and chronic inflammatory diseases
12/02/2010US20100305138 Pyridyl derivatives and their use as therapeutic agents
12/02/2010US20100305131 Substituted Aminopropionic Derivatives as Neprilysin inhibitors
12/02/2010US20100305123 Class of histone deacetylase inhibitors
12/02/2010US20100305121 Novel antagonists of the human fatty acid synthase thioesterase
12/02/2010US20100305104 Oxadiazole Diaryl Compounds
12/02/2010US20100305092 Triazole oxadiazoles derivatives
12/02/2010US20100305081 Organo-gel formulations for therapeutic applications
12/02/2010US20100305074 Niacin-based pharmaceutical compositions
12/02/2010US20100305070 Treatment or prophylaxis of proliferative conditions
12/02/2010US20100305065 Use of 4-(pyrrolidin-1-yl)quinoline compounds to kill clinically latent microorganisms
12/02/2010US20100305061 Mixed butyric-formic esters of acid polysaccharides, and their preparation and use as skin cosmetics
12/02/2010US20100305048 Novel use of cytokine inhibitors
12/02/2010US20100305047 Cyclosporin derivatives for enhancing the growth of hair
12/02/2010US20100305037 Cyclosporin derivatives for treating inflammatory diseases and conditions
12/02/2010US20100305034 Growth factor isoform
12/02/2010US20100305024 Methods of inhibiting calcineurin with apoe analogs
12/02/2010US20100303924 Process for Producing A Beverage Comprising Cocoa Material with Enhanced Polyphenol Levels
12/02/2010US20100303899 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
12/02/2010US20100303896 5beta, 14beta-androstane derivatives useful for the treatment of restenosis after angioplastic or endoartherectomy and diseases due to organ fibrosis
12/02/2010US20100303891 Supramacromolecular polymer complexes providing controlled nitric oxide release for healing wounds
12/02/2010US20100303886 Graft materials and methods for staged delivery of bioactive components
12/02/2010US20100303880 Tissue scaffolding comprising surface folds for tissue engineering
12/02/2010US20100303854 Botanical anti-acne formulations
12/02/2010US20100303823 Human monoclonal antibodies against interleukin 8 (il-8)
1 ... 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 ... 1065